March 18, 2020 / 6:19 AM / 19 days ago

BRIEF-Addex Delays Dipraglurant Pivotal Study And Report Of FY Results

March 18 (Reuters) - ADDEX THERAPEUTICS LTD:

* DELAYS START OF DIPRAGLURANT PIVOTAL STUDY AND REPORTING 2019 FULL YEAR AUDITED RESULTS

* WILL DELAY REPORTING ITS FULL YEAR 2019 AUDITED FINANCIAL RESULTS AND ASSOCIATED INVESTOR CONFERENCE CALL TILL APRIL 8, 2020

* WILL CONTINUE TO WORK WITH ITS CRO AND STUDY SITES TO CONTINUE PREPARATIONS TO START STUDY AS SOON AS IT IS APPROPRIATE TO DO SO Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below